Top

Published in:

01-04-2010 | Short Communication

Vitamin D status and parathyroid hormone relationship in adolescents and its association with bone health parameters: analysis of the Northern Ireland Young Heart’s Project

Authors: T. R. Hill, A. A. Cotter, S. Mitchell, C. A. Boreham, W. Dubitzky, L. Murray, J. J. Strain, A. Flynn, P. J. Robson, J. M. W. Wallace, M. Kiely, K. D. Cashman

Published in: Osteoporosis International | Issue 4/2010

Abstract

Summary

In girls, a plateau in parathyroid hormone (PTH) was observed at a 25-hydroxyvitamin D (25(OH)D) concentration of approximately 60 nmol/l. In boys, there was no plateau in PTH concentrations as 25(OH)D concentration increased. A 25(OH)D threshold of 60 nmol/l appears to have implications for bone health outcomes in both girls and boys.

Introduction

Our objective was to investigate if there is a threshold 25(OH)D concentration where a plateau in PTH concentration is evident and to examine the impact of this relationship on bone mineral density (BMD) and bone turnover in a representative sample of adolescents.

Methods

We conducted a cross-sectional analysis among 1,015 Northern Irish adolescents aged 12 and 15 years. Serum 25(OH)D, PTH, osteocalcin, type 1 collagen cross-linked C-telopeptide (CTx), and BMD of the nondominant forearm and heel were measured. Nonlinear regression analysis was used to model the association between 25(OH)D and PTH.

Results

In girls, a plateau in PTH was observed at a 25(OH)D concentration of approximately 60 nmol/l (PTH = 47.146 + 370.314 × exp^{(−0.092 × 25(OH)D)}) while no plateau in PTH was observed in boys (PTH = 42.144 + 56.366 × exp^{(−0.022 × 25(OH)D)}). Subjects with 25(OH)D levels <60 nmol/l had significantly higher osteocalcin concentrations (P < 0.05) compared with those who had ≥60 nmol/l, while no significant (P > 0.05) differences were noted for CTx concentrations. In girls only, nondominant forearm BMD but not heel BMD was significantly higher (P = 0.046) in those with 25(OH)D concentrations ≥ 60 nmol/l.

Conclusions

Serum 25(OH)D levels above 60 nmol/l in Northern Irish adolescent girls prevent an increase in serum PTH levels and maintaining 25(OH)D >60 nmol/l in both girls and boys may lead to improved bone health outcomes.

UK Department of Health (1998) Nutrition and bone health: with particular reference to calcium and vitamin D. Report on Health and Social Subjects (49). The Stationary Office, London

Lips P (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89–90:611–614CrossRefPubMed

Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116:2062–2072CrossRefPubMed

McKenna MJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69–77CrossRefPubMed

Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501CrossRefPubMed

Chapuy MC, Preziosi P, Maamer M et al (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439–443CrossRefPubMed

McKenna MJ, Freaney R (1998) Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8:S3–S6PubMed

Krabbe S, Transbol I, Christiansen C (1982) Bone mineral homeostasis, bone growth, and mineralization during years of pubertal growth spurt: a unifying concept. Arch Dis Child 57:359–363CrossRefPubMed

Cadogan J, Blumsohn A, Barker ME, Eastell R (1998) A longitudinal study of bone gain in pubertal girls: anthropometric. J Bone Miner Res 13:1602–1612CrossRefPubMed

10.

Cashman KD (2007) Vitamin D in childhood and adolescence. Postgrad Med J 83:230–235CrossRefPubMed

11.

Gallagher AM, Savage JM, Murray LJ et al (2002) A longitudinal study through adolescence to adulthood: the Young Hearts Project, Northern Ireland. Pub Health 116:332–340

12.

McGartland CP, Robson PJ, Murray LJ et al (2004) Fruit and vegetable consumption and bone mineral density: the Northern Ireland Young Hearts Project. Am J Clin Nutr 80:1019–1023PubMed

13.

Carter GD, Carter R, Jones J, Berry J (2004) How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 50:2195–2197CrossRefPubMed

14.

Guillemant J, Taupin P, Le HT et al (1999) Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int 10:222–225CrossRefPubMed

15.

Outila TA, Kärkkäinen MU, Lamberg-Allardt CJ (2001) Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am J Clin Nutr 74:206–210PubMed

16.

Cashman KD, Hill TR, Cotter AA et al (2008) Low vitamin D status adversely affects bone health parameters in adolescents. Am J Clin Nutr 87:1039–1044PubMed

17.

Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D₃: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D₃ synthesis in human skin. J Clin Endocrinol Metab 67:373–378CrossRefPubMed

18.

Department of Health (1991) Dietary reference values for food energy and nutrients for the UK. Report on Health and Social Subjects No 41. Stationery Office, London

19.

Boot AM, de Ridder MA, Pols HA, Krenning EP, de Muinck Keizer-Schrama SM (1997) Bone mineral density in children and adolescents: relation to puberty, calcium intake and physical activity. J Clin Endocrinol Metab 82:57–62CrossRefPubMed

20.

Frank GR (2003) Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol 41:217–221CrossRefPubMed

21.

Harkness L, Cromer B (2005) Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporos Int 16:109–113CrossRefPubMed

22.

Yan L, Prentice A, Zhang H et al (2000) Vitamin D status and parathyroid hormone concentrations in Chinese women and men from north-east of the People’s Republic of China. Am J Clin Nutr 54:68–72CrossRef

23.

Kärkkäinen MU, Wiersma JW, Lamberg-Allardt CJ (1997) Postprandial parathyroid response to four calcium-rich foodstuffs. Am J Clin Nutr 65:1726–1730PubMed

24.

Kemi VE, Kärkkäinen MU, Lamberg-Allardt CJ (2006) High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females. Br J Nutr 96:545–552PubMed

Title: Vitamin D status and parathyroid hormone relationship in adolescents and its association with bone health parameters: analysis of the Northern Ireland Young Heart’s Project
Authors: T. R. Hill
A. A. Cotter
S. Mitchell
C. A. Boreham
W. Dubitzky
L. Murray
J. J. Strain
A. Flynn
P. J. Robson
J. M. W. Wallace
M. Kiely
K. D. Cashman
Publication date: 01-04-2010
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 4/2010
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-009-0959-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Vitamin D status and parathyroid hormone relationship in adolescents and its association with bone health parameters: analysis of the Northern Ireland Young Heart’s Project

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2010

Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia

Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients

Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials

Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians

Alendronate-related femoral diaphysis fracture—what should be done to predict and prevent subsequent fracture of the contralateral side?

Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies